Müller, L.; Gairing, S.J.; Kloeckner, R.; Foerster, F.; Weinmann, A.; Mittler, J.; Stoehr, F.; Emrich, T.; Düber, C.; Galle, P.R.;
et al. Baseline Splenic Volume Outweighs Immuno-Modulated Size Changes with Regard to Survival Outcome in Patients with Hepatocellular Carcinoma under Immunotherapy. Cancers 2022, 14, 3574.
https://doi.org/10.3390/cancers14153574
AMA Style
Müller L, Gairing SJ, Kloeckner R, Foerster F, Weinmann A, Mittler J, Stoehr F, Emrich T, Düber C, Galle PR,
et al. Baseline Splenic Volume Outweighs Immuno-Modulated Size Changes with Regard to Survival Outcome in Patients with Hepatocellular Carcinoma under Immunotherapy. Cancers. 2022; 14(15):3574.
https://doi.org/10.3390/cancers14153574
Chicago/Turabian Style
Müller, Lukas, Simon Johannes Gairing, Roman Kloeckner, Friedrich Foerster, Arndt Weinmann, Jens Mittler, Fabian Stoehr, Tilman Emrich, Christoph Düber, Peter Robert Galle,
and et al. 2022. "Baseline Splenic Volume Outweighs Immuno-Modulated Size Changes with Regard to Survival Outcome in Patients with Hepatocellular Carcinoma under Immunotherapy" Cancers 14, no. 15: 3574.
https://doi.org/10.3390/cancers14153574
APA Style
Müller, L., Gairing, S. J., Kloeckner, R., Foerster, F., Weinmann, A., Mittler, J., Stoehr, F., Emrich, T., Düber, C., Galle, P. R., & Hahn, F.
(2022). Baseline Splenic Volume Outweighs Immuno-Modulated Size Changes with Regard to Survival Outcome in Patients with Hepatocellular Carcinoma under Immunotherapy. Cancers, 14(15), 3574.
https://doi.org/10.3390/cancers14153574